Zacks Investment Research Downgrades Trupanion (NASDAQ:TRUP) to Sell

Zacks Investment Research lowered shares of Trupanion (NASDAQ:TRUP) from a hold rating to a sell rating in a research note published on Saturday, Zacks.com reports.

According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “

Other equities research analysts have also recently issued reports about the company. Guggenheim reiterated a buy rating and issued a $95.00 target price (up from $90.00) on shares of VF in a research note on Thursday, May 23rd. Northland Securities set a $5.00 target price on Communications Systems and gave the company a buy rating in a research note on Tuesday, May 14th. BidaskClub cut Zynerba Pharmaceuticals from a buy rating to a hold rating in a research note on Wednesday, June 26th. Finally, ValuEngine cut Zumiez from a hold rating to a sell rating in a research note on Thursday, March 21st. One equities research analyst has rated the stock with a sell rating and twelve have given a buy rating to the company. Trupanion presently has an average rating of Buy and a consensus target price of $43.90.

Shares of TRUP opened at $34.10 on Friday. The stock’s fifty day moving average price is $33.62. Trupanion has a 12-month low of $22.38 and a 12-month high of $46.70. The company has a market capitalization of $1.21 billion, a PE ratio of -1,136.67 and a beta of 1.32. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.85 and a quick ratio of 1.85.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Thursday, May 2nd. The financial services provider reported ($0.04) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.01) by ($0.03). Trupanion had a negative return on equity of 0.59% and a negative net margin of 0.23%. The firm had revenue of $86.98 million for the quarter, compared to the consensus estimate of $85.87 million. During the same quarter last year, the business earned ($0.05) earnings per share. The business’s revenue for the quarter was up 24.7% compared to the same quarter last year. Sell-side analysts predict that Trupanion will post -0.07 EPS for the current year.

In related news, insider Darryl Rawlings sold 4,000 shares of Trupanion stock in a transaction dated Tuesday, July 2nd. The shares were sold at an average price of $35.42, for a total transaction of $141,680.00. Following the sale, the insider now directly owns 1,519,120 shares in the company, valued at $53,807,230.40. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CRO Margaret Tooth sold 750 shares of Trupanion stock in a transaction dated Tuesday, June 18th. The shares were sold at an average price of $34.69, for a total transaction of $26,017.50. The disclosure for this sale can be found here. Insiders sold 60,253 shares of company stock worth $1,915,972 over the last quarter. 13.61% of the stock is currently owned by company insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Rhumbline Advisers increased its stake in Trupanion by 52.7% during the 4th quarter. Rhumbline Advisers now owns 32,345 shares of the financial services provider’s stock valued at $824,000 after purchasing an additional 11,163 shares in the last quarter. New York State Common Retirement Fund increased its stake in Trupanion by 7.6% during the 4th quarter. New York State Common Retirement Fund now owns 65,116 shares of the financial services provider’s stock valued at $1,658,000 after purchasing an additional 4,625 shares in the last quarter. BlackRock Inc. increased its stake in Trupanion by 4.2% during the 4th quarter. BlackRock Inc. now owns 1,803,036 shares of the financial services provider’s stock valued at $45,905,000 after purchasing an additional 73,488 shares in the last quarter. Bank of New York Mellon Corp increased its stake in Trupanion by 5.4% during the 4th quarter. Bank of New York Mellon Corp now owns 93,334 shares of the financial services provider’s stock valued at $2,376,000 after purchasing an additional 4,801 shares in the last quarter. Finally, Citigroup Inc. increased its stake in Trupanion by 12,818.2% during the 4th quarter. Citigroup Inc. now owns 2,842 shares of the financial services provider’s stock valued at $72,000 after purchasing an additional 2,820 shares in the last quarter. Institutional investors and hedge funds own 97.77% of the company’s stock.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.

Read More: What is the Federal Reserve?

Get a free copy of the Zacks research report on Trupanion (TRUP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit